Stock Report

Aspira Pathlab and Diagnostics Q3FY22 profit soars to Rs. 86.94 lakhs



Posted On : 2022-02-13 21:03:59( TIMEZONE : IST )

Aspira Pathlab and Diagnostics Q3FY22 profit soars to Rs. 86.94 lakhs

Aspira Pathlab & Diagnostics Limited has reported Standalone financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 4.7482 crores during the period ended December 31, 2021 as compared to Rs. 3.5139 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. 0.8694 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 0.1446 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. 0.84 for the period ended December 31, 2021 as compared to Rs. 0.14 for the period ended September 30, 2021.

Financials Q3 FY2022 Q2 FY2022 % Change
Total Income ₹ 4.7482 crs ₹3.5139 crs Up Tick / Down Tick35.13%
Net Profit ₹0.8694 crs ₹0.1446 crs Up Tick / Down Tick501.24%
EPS ₹0.84 ₹0.14 Up Tick / Down Tick500.00%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 4.7482 crores during the period ended December 31, 2021 as compared to Rs.4.2507 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.0.8694 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.0.2554 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.0.84 for the period ended December 31, 2021 as compared to Rs.0.27 for the period ended December 31, 2020.

Financials Q3 FY2022 Q3 FY2021 % Change
Total Income ₹ 4.7482 crs ₹4.2507 crs Up Tick / Down Tick11.70%
Net Profit ₹0.8694 crs ₹0.2554 crs Up Tick / Down Tick240.41%
EPS ₹0.84 ₹0.27 Up Tick / Down Tick211.11%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.14.1681 crores during the 9 Months period ended December 31, 2021 as compared to Rs.11.2843 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.3.0174 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.0.9545 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.2.93 for the 9 Months period ended December 31, 2021 as compared to Rs.1.03 for the 9 Months period ended December 31, 2020.

Financials 9 Months Ended FY2022 9 Months Ended FY2021 % Change
Total Income ₹14.1681 crs ₹11.2843 crs Up Tick / Down Tick25.56%
Net Profit ₹3.0174 crs ₹0.9545 crs Up Tick / Down Tick216.12%
EPS ₹2.93 ₹1.03 Up Tick / Down Tick184.47%

Shares of Aspira Pathlab & Diagnostics Limited was last trading in BSE at Rs. 85.55 as compared to the previous close of Rs. 85.65. The total number of shares traded during the day was 436 in over 23 trades.

The stock hit an intraday high of Rs. 89.00 and intraday low of 83.00. The net turnover during the day was Rs. 37251.00.

Source : Equity Bulls

Keywords

AspiraPathlabandDiagnostics Q3FY22 9MFY22 ResultUpdate